46
Participants
Start Date
April 4, 2019
Primary Completion Date
January 31, 2021
Study Completion Date
November 30, 2021
ABILIFY MYCITE
Initiation of ABILIFY MYCITE will commence immediately, with subjects wearing the patch and using the smartphone app for a total of 3 months from baseline visit to the 3 month visit. Following the initial 90-days, the physician and patient may determine to use ABILIFY MYCITE anytime during the following 9 months. Following this period (up to 12 months), the subjects will not use ABILIFY MYCITE and return to standard care. A safety follow-up phone call will occur at 2 weeks after the 12 month/early termination (ET) visit. In addition, individuals in the ABILIFY MYCITE arm will evaluate satisfaction with the use of ABILIFY MYCITE.
Durham VA Medical Center, Durham
Michael E. DeBakey VA Medical Center, Houston
Lead Sponsor
Otsuka Pharmaceutical Development and Commercialization, Inc.
UNKNOWN
Durham VA Medical Center
FED